Paper42226292
FTO-modulated m6A demethylation and upregulation of KIF11 mRNA promotes retinal microvascular dysfunction in diabetic retinopathy.
Lin C and 5 others. J Transl Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. FTO-modulated m6A demethylation and upregulation of KIF11 mRNA promotes retinal microvascular dysfunction in diabetic retinopathy. Papers, record 42226292. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226292
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- FTO-modulated m6A demethylation and upregulation of KIF11 mRNA promotes retinal microvascular dysfunction in diabetic retinopathy.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Demethylation | Major topic |
| Up-Regulation | Major topic |
| Kinesins | Major topic |
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | Major topic |
| Diabetic Retinopathy | Major topic |
| Adenosine | Major topic |
| Microvessels | Major topic |
| Retina | Major topic |
| Retinal Vessels | Major topic |
| Animals | |
| Humans | |
| RNA, Messenger | |
| RNA Methylation | |
| Rats, Sprague-Dawley | |
| Male | |
| Rats | |
| Cell Proliferation | |
| Diabetes Mellitus, Experimental | |
| Cell Movement | |
| Endothelial Cells | |
| Epitranscriptome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2020M671541 | China Postdoctoral Science Foundation | PubMed | ||
| BJ2023017 | Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee | PubMed |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39265509 | MG53 suppresses tumor growth via transcriptional inhibition of KIF11 in pancreatic cancer. | Transl Oncol | 2024 | https://conductscience.org/library/papers/39265509 | PubMed |
| 2 | 30996080 | Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1. | Sci Transl Med | 2019 | https://conductscience.org/library/papers/30996080 | PubMed |
| 3 | 40485587 | FTO inhibition enhances the therapeutic index of radiation therapy in head and neck cancer. | JCI Insight | 2025 | https://conductscience.org/library/papers/40485587 | PubMed |
| 4 | 32398132 | The potential role of RNA N6-methyladenosine in Cancer progression. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32398132 | PubMed |
| 5 | 40427510 | The Role of N6-Methyladenosine (m6A) RNA Modification in the Pathogenesis of Parkinson's Disease. | Biomolecules | 2025 | https://conductscience.org/library/papers/40427510 | PubMed |
| 6 | 39910282 | The evolution of diabetic retinopathy screening. | Eye (Lond) | 2025 | https://conductscience.org/library/papers/39910282 | PubMed |
| 7 | 32290826 | Identification of potential molecular targets associated with proliferative diabetic retinopathy. | BMC Ophthalmol | 2020 | https://conductscience.org/library/papers/32290826 | PubMed |
| 8 | 41009541 | Kinesin Spindle Protein (KIF11) in Mitosis and Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009541 | PubMed |
| 9 | 37697295 | Research progress on the pathogenesis of diabetic retinopathy. | BMC Ophthalmol | 2023 | https://conductscience.org/library/papers/37697295 | PubMed |
| 10 | 40053164 | FTO-mediated Nrf2 demethylation alleviates high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40053164 | PubMed |
| 11 | 36411543 | Clinical characteristics and mutation spectrum in 33 Chinese families with familial exudative vitreoretinopathy. | Ann Med | 2022 | https://conductscience.org/library/papers/36411543 | PubMed |
| 12 | 37318823 | Diabetic Retinopathy in the US-Where We Are Now and What Is Next. | JAMA Ophthalmol | 2023 | https://conductscience.org/library/papers/37318823 | PubMed |
| 13 | 39304899 | FTO-mediated DSP m6A demethylation promotes an aggressive subtype of growth hormone-secreting pituitary neuroendocrine tumors. | Mol Cancer | 2024 | https://conductscience.org/library/papers/39304899 | PubMed |
| 14 | 37567360 | The hsa_circ_0004805/hsa_miR-149-5p/TGFB2 axis plays critical roles in the pathophysiology of diabetic retinopathy in vitro and in vivo. | Mol Cell Endocrinol | 2023 | https://conductscience.org/library/papers/37567360 | PubMed |
| 15 | 38913865 | Reprogramming of RNA m6A Modification Is Required for Acute Myeloid Leukemia Development. | Genomics Proteomics Bioinformatics | 2025 | https://conductscience.org/library/papers/38913865 | PubMed |
| 16 | 40253339 | Peptides based on the interface of hnRNPA2B1-transthyretin complex repress retinal angiogenesis in diabetic retinopathy. | J Transl Med | 2025 | https://conductscience.org/library/papers/40253339 | PubMed |
| 17 | 31100245 | Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. | Mol Cell | 2019 | https://conductscience.org/library/papers/31100245 | PubMed |
| 18 | 40083702 | TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40083702 | PubMed |
| 19 | 39492320 | m6A epitranscriptomic modification in diabetic microvascular complications. | Trends Pharmacol Sci | 2023 | https://conductscience.org/library/papers/39492320 | PubMed |
| 20 | 39744011 | FTO in health and disease. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39744011 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| FTO | 79068 | PubTator's text mining | https://conductscience.org/library/genes/79068 | NCBI Gene |
| KIF11 | 3832 | PubTator's text mining | https://conductscience.org/library/genes/3832 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42226292
GET https://conductscience.org/api/papers/v1/42226292/references?page=2